SymBiosis Capital Partners, LLC
CIK
2006045
Location
BENTONVILLE, AR
Portfolio Value
Micro
$52,768,253
Diversification
Highly concentrated
Filing Date
Global Rank
#6,411
/ 8,232
▼ 753
Top Industry
Biotechnology
96.0%
3Y Alpha vs SPY
-98.3%
Period ended 2 months ago
Filed May 12, 2026 · 32d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-30.8%
SPY
+9.1%
Annualised alpha
-98.3%
Max drawdown
−31.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
5 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
55.8%
+33.9 pts
Top 5
100.0%
+26.9 pts
Top 10
100.0%
0.0 pts
HHI
3,875
Highly concentrated+2,540
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 96.0% | $50,642,960 |
| Consumer Defensive | 4.0% | $2,125,293 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | 750,000 | $5,437,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VSTM | Verastem, Inc. | 2,000,000 | $15,440,000 | |
| PGEN | Precigen, Inc. | 3,000,000 | $12,540,000 | |
| NUVB | Nuvation Bio Inc. | 1,250,000 | $11,200,000 | |
| AMPG | AmpliTech Group, Inc. | 2,555,000 | $7,639,450 | |
| AARD | Aardvark Therapeutics, Inc. | 476,595 | $6,255,309 | |
| No positions match the current search. | ||||
5 positions ·
$52,768,253 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 1,280,778 | $29,445,086 | 55.80% | |
| IVA |
Inventiva S.A.
Healthcare
|
Reduced | 2,354,000 | $13,064,700 | 24.76% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
NEW | 750,000 | $5,437,500 | 10.30% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
Reduced | 3,667,585 | $2,695,674 | 5.11% | |
| CLNN |
Clene Inc.
Consumer Defensive
|
Reduced | 431,094 | $2,125,293 | 4.03% |